Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Clinical trial NCT02924376 · COMPLETED
Trial details
- NCT number
- NCT02924376
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-16
- Primary completion
- 2022-02-01
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.